Skip to main content
Erschienen in: Endocrine 2/2014

01.03.2014 | Original Article

MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation

verfasst von: Mingliang Zhou, Junrong Ma, Shiju Chen, Xiang Chen, Xijie Yu

Erschienen in: Endocrine | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

MicroRNAs (miRNAs) have been identified to play important functions during osteoblast proliferation, differentiation, and apoptosis. The miR-17~92 cluster is highly conserved in all vertebrates. Loss-of-function of the miR-17-92 cluster results in smaller embryos and immediate postnatal death of all animals. Germline hemizygous deletions of MIR17HG are accounted for microcephaly, short stature, and digital abnormalities in a few cases of Feingold syndrome. These reports indicate that miR-17~92 may play important function in skeletal development and mature. To determine the functional roles of miR-17~92 in bone metabolism as well as osteoblast proliferation and differentiation. Murine embryonic stem cells D3 and osteoprogenitor cell line MC3T3-E1 were induced to differentiate into osteoblasts; the expression of miR-17-92 was assayed by quantitative real-time RT-PCR. The skeletal phenotypes were assayed in mice heterozygous for miR-17~92 (miR-17~92 + ). To determine the possibly direct function of miR-17~92 in bone cells, osteoblasts from miR-17~92 + mice were investigated by ex vivo cell culture. miR-17, miR-92a, and miR-20a within miR-17-92 cluster were expressed at high level in bone tissue and osteoblasts. The expression of miR-17-92 was down-regulated along with osteoblast differentiation, the lowest level was found in mature osteoblasts. Compared to wildtype controls, miR-17-92 + mice showed significantly lower trabecular and cortical bone mineral density, bone volume and trabecular number at 10 weeks old. mRNA expression of Runx2 and type I collagen was significantly lower in bone from miR-17-92 + mice. Osteoblasts from miR-17-92 + mice showed lower proliferation rate, ALP activity and less calcification. Our research suggests that the miR-17-92 cluster critically regulates bone metabolism, and this regulation is mostly through its function in osteoblasts.
Literatur
1.
Zurück zum Zitat L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, J.M. Johnson, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027), 769–773 (2005). doi:10.1038/nature03315 PubMedCrossRef L.P. Lim, N.C. Lau, P. Garrett-Engele, A. Grimson, J.M. Schelter, J. Castle, D.P. Bartel, P.S. Linsley, J.M. Johnson, Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027), 769–773 (2005). doi:10.​1038/​nature03315 PubMedCrossRef
2.
Zurück zum Zitat A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, M. Seto, Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64(9), 3087–3095 (2004)PubMedCrossRef A. Ota, H. Tagawa, S. Karnan, S. Tsuzuki, A. Karpas, S. Kira, Y. Yoshida, M. Seto, Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64(9), 3087–3095 (2004)PubMedCrossRef
3.
Zurück zum Zitat S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103(7), 2257–2261 (2006). doi:0510565103 PubMedCrossRef S. Volinia, G.A. Calin, C.G. Liu, S. Ambs, A. Cimmino, F. Petrocca, R. Visone, M. Iorio, C. Roldo, M. Ferracin, R.L. Prueitt, N. Yanaihara, G. Lanza, A. Scarpa, A. Vecchione, M. Negrini, C.C. Harris, C.M. Croce, A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 103(7), 2257–2261 (2006). doi:0510565103 PubMedCrossRef
5.
Zurück zum Zitat L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, S.M. Hammond, A microRNA polycistron as a potential human oncogene. Nature 435(7043), 828–833 (2005). doi:nature03552 PubMedCrossRef L. He, J.M. Thomson, M.T. Hemann, E. Hernando-Monge, D. Mu, S. Goodson, S. Powers, C. Cordon-Cardo, S.W. Lowe, G.J. Hannon, S.M. Hammond, A microRNA polycistron as a potential human oncogene. Nature 435(7043), 828–833 (2005). doi:nature03552 PubMedCrossRef
8.
Zurück zum Zitat B.D. Aguda, Y. Kim, M.G. Piper-Hunter, A. Friedman, C.B. Marsh, MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl. Acad. Sci. USA 105(50), 19678–19683 (2008). doi:10.1073/pnas.0811166106 PubMedCrossRef B.D. Aguda, Y. Kim, M.G. Piper-Hunter, A. Friedman, C.B. Marsh, MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc. Proc. Natl. Acad. Sci. USA 105(50), 19678–19683 (2008). doi:10.​1073/​pnas.​0811166106 PubMedCrossRef
11.
Zurück zum Zitat A. Ventura, A.G. Young, M.M. Winslow, L. Lintault, A. Meissner, S.J. Erkeland, J. Newman, R.T. Bronson, D. Crowley, J.R. Stone, R. Jaenisch, P.A. Sharp, T. Jacks, Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5), 875–886 (2008). doi:10.1016/j.cell.2008.02.019 PubMedCentralPubMedCrossRef A. Ventura, A.G. Young, M.M. Winslow, L. Lintault, A. Meissner, S.J. Erkeland, J. Newman, R.T. Bronson, D. Crowley, J.R. Stone, R. Jaenisch, P.A. Sharp, T. Jacks, Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132(5), 875–886 (2008). doi:10.​1016/​j.​cell.​2008.​02.​019 PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Y. Lu, J.M. Thomson, H.Y. Wong, S.M. Hammond, B.L. Hogan, Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310(2), 442–453 (2007). doi:S0012-1606(07)01252-3 PubMedCentralPubMedCrossRef Y. Lu, J.M. Thomson, H.Y. Wong, S.M. Hammond, B.L. Hogan, Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev. Biol. 310(2), 442–453 (2007). doi:S0012-1606(07)01252-3 PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat L. de Pontual, E. Yao, P. Callier, L. Faivre, V. Drouin, S. Cariou, A. Van Haeringen, D. Genevieve, A. Goldenberg, M. Oufadem, S. Manouvrier, A. Munnich, J.A. Vidigal, M. Vekemans, S. Lyonnet, A. Henrion-Caude, A. Ventura, J. Amiel, Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43(10), 1026–1030 (2011). doi:10.1038/ng.915 PubMedCentralPubMedCrossRef L. de Pontual, E. Yao, P. Callier, L. Faivre, V. Drouin, S. Cariou, A. Van Haeringen, D. Genevieve, A. Goldenberg, M. Oufadem, S. Manouvrier, A. Munnich, J.A. Vidigal, M. Vekemans, S. Lyonnet, A. Henrion-Caude, A. Ventura, J. Amiel, Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat. Genet. 43(10), 1026–1030 (2011). doi:10.​1038/​ng.​915 PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Y. Liu, W. Liu, C. Hu, Z. Xue, G. Wang, B. Ding, H. Luo, L. Tang, X. Kong, X. Chen, N. Liu, Y. Ding, Y. Jin, MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells 29(11), 1804–1816 (2011)PubMedCrossRef Y. Liu, W. Liu, C. Hu, Z. Xue, G. Wang, B. Ding, H. Luo, L. Tang, X. Kong, X. Chen, N. Liu, Y. Ding, Y. Jin, MiR-17 modulates osteogenic differentiation through a coherent feed-forward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells 29(11), 1804–1816 (2011)PubMedCrossRef
15.
Zurück zum Zitat J.E. Onyia, B. Miller, J. Hulman, J. Liang, R. Galvin, C. Frolik, S. Chandrasekhar, A.K. Harvey, J. Bidwell, J. Herring, J.M. Hock, Proliferating cells in the primary spongiosa express phenotype in vitro. Bone 20(2), 93–100 (1997). doi:S875632829600350X PubMedCrossRef J.E. Onyia, B. Miller, J. Hulman, J. Liang, R. Galvin, C. Frolik, S. Chandrasekhar, A.K. Harvey, J. Bidwell, J. Herring, J.M. Hock, Proliferating cells in the primary spongiosa express phenotype in vitro. Bone 20(2), 93–100 (1997). doi:S875632829600350​X PubMedCrossRef
17.
Zurück zum Zitat T.C. Doetschman, H. Eistetter, M. Katz, W. Schmidt, R. Kemler, The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27–45 (1985)PubMed T.C. Doetschman, H. Eistetter, M. Katz, W. Schmidt, R. Kemler, The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27–45 (1985)PubMed
18.
Zurück zum Zitat L. Duplomb, M. Dagouassat, P. Jourdon, D. Heymann, Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells 25(3), 544–552 (2007). doi:2006-0395 PubMedCrossRef L. Duplomb, M. Dagouassat, P. Jourdon, D. Heymann, Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells 25(3), 544–552 (2007). doi:2006-0395 PubMedCrossRef
19.
Zurück zum Zitat L. Duplomb, M. Dagouassat, P. Jourdon, D. Heymann, Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body. In Vitro Cell. Dev. Biol. Anim. 43(1), 21–24 (2007). doi:10.1007/s11626-006-9010-4 PubMedCrossRef L. Duplomb, M. Dagouassat, P. Jourdon, D. Heymann, Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body. In Vitro Cell. Dev. Biol. Anim. 43(1), 21–24 (2007). doi:10.​1007/​s11626-006-9010-4 PubMedCrossRef
20.
Zurück zum Zitat T. Xia, Y. Liang, J. Ma, M. Li, M. Gong, X. Yu, Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Endocrine 39(2), 104–112 (2011)PubMedCrossRef T. Xia, Y. Liang, J. Ma, M. Li, M. Gong, X. Yu, Loss-of-function of SHARPIN causes an osteopenic phenotype in mice. Endocrine 39(2), 104–112 (2011)PubMedCrossRef
21.
Zurück zum Zitat M. Suzuki, H. Kobayashi, N. Kanayama, Y. Saga, M. Suzuki, C.Y. Lin, R.B. Dickson, T. Terao, Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J. Biol. Chem. 279(15), 14899–14908 (2004)PubMedCrossRef M. Suzuki, H. Kobayashi, N. Kanayama, Y. Saga, M. Suzuki, C.Y. Lin, R.B. Dickson, T. Terao, Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J. Biol. Chem. 279(15), 14899–14908 (2004)PubMedCrossRef
22.
Zurück zum Zitat S.H. Lee, J.S. Kim, H.K. Jun, H.R. Lee, D. Lee, B.K. Choi, The major outer membrane protein of a periodontopathogen induces IFN-beta and IFN-stimulated genes in monocytes via lipid raft and TANK-binding kinase 1/IFN regulatory factor-3. J. Immunol. 182(9), 5823–5835 (2009)PubMedCrossRef S.H. Lee, J.S. Kim, H.K. Jun, H.R. Lee, D. Lee, B.K. Choi, The major outer membrane protein of a periodontopathogen induces IFN-beta and IFN-stimulated genes in monocytes via lipid raft and TANK-binding kinase 1/IFN regulatory factor-3. J. Immunol. 182(9), 5823–5835 (2009)PubMedCrossRef
23.
Zurück zum Zitat Z. Li, M.Q. Hassan, M. Jafferji, R.I. Aqeilan, R. Garzon, C.M. Croce, A.J. van Wijnen, J.L. Stein, G.S. Stein, J.B. Lian, Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 284(23), 15676–15684 (2009). doi:10.1074/jbc.M809787200M809787200 PubMedCrossRef Z. Li, M.Q. Hassan, M. Jafferji, R.I. Aqeilan, R. Garzon, C.M. Croce, A.J. van Wijnen, J.L. Stein, G.S. Stein, J.B. Lian, Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 284(23), 15676–15684 (2009). doi:10.​1074/​jbc.​M809787200M80978​7200 PubMedCrossRef
24.
Zurück zum Zitat A. Palmieri, F. Pezzetti, G. Brunelli, M. Martinelli, L. Scapoli, M. Arlotti, E. Masiero, F. Carinci, Medpor regulates osteoblast’s microRNAs. Biomed. Mater. Eng. 18(2), 91–97 (2008)PubMed A. Palmieri, F. Pezzetti, G. Brunelli, M. Martinelli, L. Scapoli, M. Arlotti, E. Masiero, F. Carinci, Medpor regulates osteoblast’s microRNAs. Biomed. Mater. Eng. 18(2), 91–97 (2008)PubMed
25.
Zurück zum Zitat Y. Mizuno, Y. Tokuzawa, Y. Ninomiya, K. Yagi, Y. Yatsuka-Kanesaki, T. Suda, T. Fukuda, T. Katagiri, Y. Kondoh, T. Amemiya, H. Tashiro, Y. Okazaki, miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583(13), 2263–2268 (2009). doi:10.1016/j.febslet.2009.06.006 PubMedCrossRef Y. Mizuno, Y. Tokuzawa, Y. Ninomiya, K. Yagi, Y. Yatsuka-Kanesaki, T. Suda, T. Fukuda, T. Katagiri, Y. Kondoh, T. Amemiya, H. Tashiro, Y. Okazaki, miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Lett. 583(13), 2263–2268 (2009). doi:10.​1016/​j.​febslet.​2009.​06.​006 PubMedCrossRef
26.
Zurück zum Zitat J. Zhang, Q. Tu, L.F. Bonewald, X. He, G. Stein, J. Lian, J. Chen, Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J. Bone Miner. Res. 26(8), 1953–1963 (2011). doi:10.1002/jbmr.377 PubMedCrossRef J. Zhang, Q. Tu, L.F. Bonewald, X. He, G. Stein, J. Lian, J. Chen, Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J. Bone Miner. Res. 26(8), 1953–1963 (2011). doi:10.​1002/​jbmr.​377 PubMedCrossRef
27.
Zurück zum Zitat R. Hu, W. Liu, H. Li, L. Yang, C. Chen, Z.Y. Xia, L.J. Guo, H. Xie, H.D. Zhou, X.P. Wu, X.H. Luo, A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 286(14), 12328–12339 (2011). doi:10.1074/jbc.M110.176099 PubMedCrossRef R. Hu, W. Liu, H. Li, L. Yang, C. Chen, Z.Y. Xia, L.J. Guo, H. Xie, H.D. Zhou, X.P. Wu, X.H. Luo, A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 286(14), 12328–12339 (2011). doi:10.​1074/​jbc.​M110.​176099 PubMedCrossRef
28.
Zurück zum Zitat Z. Li, M.Q. Hassan, S. Volinia, A.J. van Wijnen, J.L. Stein, C.M. Croce, J.B. Lian, G.S. Stein, A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. USA 105(37), 13906–13911 (2008). doi:10.1073/pnas.0804438105 PubMedCrossRef Z. Li, M.Q. Hassan, S. Volinia, A.J. van Wijnen, J.L. Stein, C.M. Croce, J.B. Lian, G.S. Stein, A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc. Natl. Acad. Sci. USA 105(37), 13906–13911 (2008). doi:10.​1073/​pnas.​0804438105 PubMedCrossRef
30.
Zurück zum Zitat Y. Zhang, R.L. Xie, C.M. Croce, J.L. Stein, J.B. Lian, A.J. van Wijnen, G.S. Stein, A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc. Natl. Acad. Sci. USA 108(24), 9863–9868 (2011). doi:10.1073/pnas.1018493108 PubMedCrossRef Y. Zhang, R.L. Xie, C.M. Croce, J.L. Stein, J.B. Lian, A.J. van Wijnen, G.S. Stein, A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc. Natl. Acad. Sci. USA 108(24), 9863–9868 (2011). doi:10.​1073/​pnas.​1018493108 PubMedCrossRef
31.
Zurück zum Zitat L. Guo, J. Xu, J. Qi, L. Zhang, J. Wang, J. Liang, N. Qian, H. Zhou, L. Wei, L. Deng, MicroRNA-17~92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblasts apoptosis. J. Cell Sci. (2012). doi:10.1242/jcs.117515 L. Guo, J. Xu, J. Qi, L. Zhang, J. Wang, J. Liang, N. Qian, H. Zhou, L. Wei, L. Deng, MicroRNA-17~92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblasts apoptosis. J. Cell Sci. (2012). doi:10.​1242/​jcs.​117515
33.
Zurück zum Zitat J.K. Van Camp, S. Beckers, D. Zegers, E. Boudin, T.L. Nielsen, M. Andersen, G. Roef, Y. Taes, K. Brixen, W. Van Hul, Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Bmaleselgian. Endocrine (2013). doi:10.1007/s12020-012-9869-7 J.K. Van Camp, S. Beckers, D. Zegers, E. Boudin, T.L. Nielsen, M. Andersen, G. Roef, Y. Taes, K. Brixen, W. Van Hul, Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Bmaleselgian. Endocrine (2013). doi:10.​1007/​s12020-012-9869-7
34.
Zurück zum Zitat Y.H. Deng, L. Zhao, M.J. Zhang, C.M. Pan, S.X. Zhao, H.Y. Zhao, L.H. Sun, B. Tao, H.D. Song, W.Q. Wang, G. Ning, J.M. Liu, The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. Endocrine 43(1), 127–135 (2013). doi:10.1007/s12020-012-9726-8 PubMedCrossRef Y.H. Deng, L. Zhao, M.J. Zhang, C.M. Pan, S.X. Zhao, H.Y. Zhao, L.H. Sun, B. Tao, H.D. Song, W.Q. Wang, G. Ning, J.M. Liu, The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women. Endocrine 43(1), 127–135 (2013). doi:10.​1007/​s12020-012-9726-8 PubMedCrossRef
Metadaten
Titel
MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation
verfasst von
Mingliang Zhou
Junrong Ma
Shiju Chen
Xiang Chen
Xijie Yu
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-9986-y

Weitere Artikel der Ausgabe 2/2014

Endocrine 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.